DBV Technologies SA (DBVT)
3.185
+0.20
(+6.88%)
USD |
NASDAQ |
Dec 27, 16:00
3.14
-0.04
(-1.41%)
After-Hours: 20:00
DBV Technologies Cash from Investing (Quarterly): -0.109M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Edap TMS SA | -1.120M |
| Cellectis SA | 22.33M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | -66.02M |
| Akari Therapeutics PLC | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.46M |
| Cash from Financing (Quarterly) | 0.007M |
| Free Cash Flow | -108.72M |
| Free Cash Flow Per Share (Quarterly) | -1.188 |
| Free Cash Flow Yield | -177.5% |